Physician profile
Kurt Thomas Steele
NPI 1366420267
$90,044.17
in general payments reported to CMS, 2019-2025
21 companies · $1,315 in 2025
The $1,315 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66K · 2020: $11K · 2021: $4,532 · 2022: $2,024 · 2023: $3,162 · 2024: $2,077 · 2025: $1,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,638 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $867 · Consulting Fee: $500 · Entertainment: $49.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,638.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $866.57 |
| Consulting Fee | $500.00 |
| Entertainment | $49.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $66,946.90 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Maculogix, INC. | $15,905.53 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $1,690.67 | 2022-2025 | Infuse, Vyzulta, Lotemax |
| Johnson & Johnson Vision Care, INC. | $1,618.69 | 2019-2023 | Acuvue |
| Alcon Vision LLC | $841.14 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Abbvie INC. | $551.12 | 2022-2025 | |
| Lkc Technologies, INC. | $522.34 | 2023-2025 | |
| Optovue, INC. | $315.58 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $287.60 | 2024-2025 | Xdemvy |
| Topcon Healthcare, INC. | $223.20 | 2024-2025 | |
| Biotissue Holdings INC. | $208.62 | 2021-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $207.99 | 2019-2020 | |
| Optos, INC. | $155.86 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Sight Sciences, INC. | $151.80 | 2022 | |
| Dompe US, INC. | $84.85 | 2024-2025 | Oxervate |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $82.28 | 2023-2025 | Acthar |
| Shire North American Group INC | $81.70 | 2019 | |
| Horizon Therapeutics Plc | $80.00 | 2022 | |
| Lombart Brothers, INC. | $50.00 | 2024 | Opd-III |
| Harrow Eye, LLC | $23.54 | 2024 | Vevye |
| Allergan, INC. | $14.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.